HGH Frag 176-191 Ipamorelin CJC DAC

Product Overview

The HGH Frag 176-191 Ipamorelin CJC DAC blend available at Direct Anti Peptide represents a sophisticated multi-component research peptide formulation designed to support advanced scientific inquiry. This blend integrates three well-characterized peptide agents into a single lyophilized preparation, offering researchers a convenient and analytically verified substrate for exploring synergistic interactions between lipolytic signaling, growth hormone secretagogue activity, and extended-release hormonal modulation. All components are manufactured to ≥98% purity and are intended exclusively for qualified laboratory and research professionals.

Peptide Structure & Amino Acid Sequence

Each component of this blend carries a distinct structural identity. HGH Fragment 176-191 is a truncated synthetic analogue of the C-terminal region of human growth hormone, corresponding to amino acid positions 176 through 191. Its sequence — Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe — retains the lipolytic domain of native HGH without engaging growth-promoting receptors. Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) is a selective pentapeptide ghrelin mimetic and growth hormone secretagogue receptor (GHSR) agonist notable for its high receptor selectivity. CJC-1295 DAC is a tetrasubstituted analogue of growth hormone-releasing hormone (GHRH) conjugated with a Drug Affinity Complex (DAC) technology that covalently binds to circulating albumin, dramatically extending its plasma half-life and making it a valuable model for studying prolonged GHRH receptor activation in preclinical research contexts.

Chemical & Physical Characteristics

• Blend Composition: HGH Fragment 176-191 (6mg), Ipamorelin (3mg), CJC-1295 DAC (3mg)
• Total Blend Weight: 12mg per vial
• Physical Form: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffers; suitable for standard laboratory reconstitution protocols
• Molecular Weights: HGH Frag 176-191 ~1817 Da; Ipamorelin ~711 Da; CJC-1295 DAC ~3647 Da
• Storage Temperature: −20°C (long-term); 2–8°C (short-term after reconstitution)

Purity & Analytical Verification (HPLC & MS)

Every batch of this research blend produced for Direct Anti Peptide undergoes rigorous analytical testing prior to release. High-Performance Liquid Chromatography (HPLC) is employed to confirm that each individual peptide component meets or exceeds the ≥98% purity threshold. Mass Spectrometry (MS) analysis validates the molecular integrity and correct amino acid composition of each component, ensuring that no degradation products, adducts, or impurities compromise the research value of the final formulation. Certificates of Analysis (CoA) reflecting these results are available upon request.

Quality Control & Lyophilization Integrity

The blend is processed under controlled lyophilization conditions to preserve peptide stability, biological activity potential in research models, and long-term shelf integrity. Lyophilization removes residual moisture to levels that prevent hydrolytic degradation, ensuring that researchers receive a consistent and stable substrate across every order. Batch-to-batch consistency is maintained through standardized manufacturing protocols, and each vial is sealed under inert conditions to prevent oxidative compromise during storage and transit.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by trained research scientists and laboratory professionals operating within appropriately equipped facilities. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and appropriate lab attire — should be worn at all times when handling lyophilized peptide powders or reconstituted solutions. Researchers should consult relevant Safety Data Sheets (SDS) and institutional biosafety protocols before use. This product is not approved for human or animal administration under any circumstances.

Reconstitution, Packaging & Storage

This blend is supplied as a lyophilized powder in a sealed research vial. Reconstitution should follow standard laboratory procedures appropriate to the intended assay or experimental design, using sterile aqueous solvents as dictated by institutional protocols. Once reconstituted, solutions should be stored at 2–8°C and used within timeframes consistent with established peptide stability guidelines. For long-term archival storage, maintain the lyophilized vial at −20°C away from light and moisture. Packaging is designed to maintain product integrity during international shipping and laboratory handling.

Intended Research Use & Market Positioning

This triple-component blend is positioned as a premium research tool for investigators studying the intersecting pathways of growth hormone secretion, lipolysis regulation, and extended peptide pharmacokinetics. The combination of a lipolytic HGH fragment, a selective GHS-R agonist, and a long-acting GHRH analogue in a single formulation allows researchers to design experiments exploring potential synergistic or additive interactions across these mechanistic axes. It is ideally suited for cell-based assays, receptor binding studies, and in vitro metabolic research models. Direct Anti Peptide offers this blend as part of a broader catalog of high-purity research peptides for sale, serving academic institutions, private research organizations, and licensed laboratory facilities worldwide.

Ordering, Availability & Fulfillment

Researchers looking to buy HGH Frag 176-191 Ipamorelin CJC DAC online can order now directly through Direct Anti Peptide with confidence. We offer competitive best-price positioning, secure checkout, and reliable international fulfillment. All orders are processed promptly, with discreet and protective packaging to ensure product integrity upon arrival. Our team is available to assist with bulk ordering inquiries, CoA documentation requests, and research-specific product questions. This peptide blend is in stock and available for immediate dispatch.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product has not been evaluated or approved by the FDA, EMA, or any other regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals. It is the sole responsibility of the purchasing researcher or institution to ensure compliance with all applicable local, national, and international laws and regulations governing the purchase, possession, and use of research peptides. Direct Anti Peptide assumes no liability for misuse, improper handling, or use outside of a qualified research context.